Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
176.49
+0.85 (0.48%)
Nov 19, 2024, 3:39 PM EST - Market open
Krystal Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 241.52 | 50.7 | - | - | - | - | Upgrade
|
| Cost of Revenue | 17.98 | 3.09 | - | - | - | - | Upgrade
|
| Gross Profit | 223.54 | 47.61 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 107.16 | 98.4 | 78.84 | 41.99 | 15.06 | 6.47 | Upgrade
|
| Research & Development | 51.42 | 46.43 | 42.46 | 27.88 | 17.94 | 15.62 | Upgrade
|
| Operating Expenses | 158.58 | 144.83 | 121.3 | 69.88 | 33 | 22.08 | Upgrade
|
| Operating Income | 64.95 | -97.23 | -121.3 | -69.88 | -33 | -22.08 | Upgrade
|
| Interest Expense | - | - | - | -1.49 | - | - | Upgrade
|
| Interest & Investment Income | 29.95 | 22.62 | 5.22 | 0.2 | 0.83 | 2.99 | Upgrade
|
| EBT Excluding Unusual Items | 94.9 | -74.6 | -116.08 | -71.17 | -32.17 | -19.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 100 | - | - | - | - | Upgrade
|
| Legal Settlements | -37.5 | -12.5 | -25 | - | - | - | Upgrade
|
| Pretax Income | 57.4 | 12.9 | -139.98 | -69.57 | -32.17 | -19.09 | Upgrade
|
| Income Tax Expense | 5.03 | 1.97 | - | - | - | - | Upgrade
|
| Net Income | 52.37 | 10.93 | -139.98 | -69.57 | -32.17 | -19.09 | Upgrade
|
| Net Income to Common | 52.37 | 10.93 | -139.98 | -69.57 | -32.17 | -19.09 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 27 | 25 | 22 | 19 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 28 | 25 | 22 | 19 | 16 | Upgrade
|
| Shares Change (YoY) | 11.06% | 8.87% | 14.84% | 18.15% | 18.15% | 41.93% | Upgrade
|
| EPS (Basic) | 1.84 | 0.40 | -5.49 | -3.13 | -1.71 | -1.20 | Upgrade
|
| EPS (Diluted) | 1.77 | 0.39 | -5.49 | -3.13 | -1.71 | -1.20 | Upgrade
|
| Free Cash Flow | 58.06 | -100.6 | -153.55 | -116.27 | -40.93 | -25.09 | Upgrade
|
| Free Cash Flow Per Share | 1.97 | -3.63 | -6.02 | -5.24 | -2.18 | -1.58 | Upgrade
|
| Gross Margin | 92.55% | 93.90% | - | - | - | - | Upgrade
|
| Operating Margin | 26.89% | -191.77% | - | - | - | - | Upgrade
|
| Profit Margin | 21.68% | 21.56% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 24.04% | -198.43% | - | - | - | - | Upgrade
|
| EBITDA | 69.15 | -92.22 | -117.24 | -67.11 | -31.15 | -20.99 | Upgrade
|
| EBITDA Margin | 28.63% | -181.90% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 4.19 | 5.01 | 4.06 | 2.77 | 1.85 | 1.09 | Upgrade
|
| EBIT | 64.95 | -97.23 | -121.3 | -69.88 | -33 | -22.08 | Upgrade
|
| EBIT Margin | 26.89% | -191.77% | - | - | - | - | Upgrade
|
| Effective Tax Rate | 8.76% | 15.24% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.